6949.TW
Price:
$121
Market Cap:
$6.99B
Pell Bio-Med Technology Co., Ltd., a biomedical company, engages in the development of cell culture technologies and techniques for therapeutic applications. Its commercial products include good tissue practice laboratory infrastructure, adipose-derived stem cells (ADSC) for regenerative medicine, and CIK and DC-CIK against cancers. The company also develops medicines for various types of cancers, cell immunotherapy, and stem cell regenerative therapy technologies. In addition, it engages in the research and development of chimeric antigen receptor T cell (CAR-T), CAR-NK and CAR-?dT, and gene-modified ADSC. Further, the company develops products for B-NHL, ovarian cancer, multiple myeloma, a...[Read more]
Industry
Biotechnology
IPO Date
Stock Exchange
TAI
Ticker
6949.TW
According to Pell Bio-Med Technology Co., Ltd.’s latest financial reports and current stock price. The company's current ROE is -29.80%. This represents a change of 296.65% compared to the average of -7.51% of the last 4 quarters.
The mean historical ROE of Pell Bio-Med Technology Co., Ltd. over the last ten years is -44.96%. The current -29.80% ROE has changed -33.72% with respect to the historical average. Over the past ten years (40 quarters), 6949.TW's ROE was at its highest in in the September 2022 quarter at 0%. The ROE was at its lowest in in the September 2023 quarter at -18.33%.
Average
-44.96%
Median
-33.54%
Minimum
-84.03%
Maximum
-28.73%
Discovering the peaks and valleys of Pell Bio-Med Technology Co., Ltd. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 18.60%
Maximum Annual ROE = -28.73%
Minimum Annual Increase = -65.81%
Minimum Annual ROE = -84.03%
Year | ROE | Change |
---|---|---|
2024 | -33.00% | -3.15% |
2023 | -34.08% | 18.60% |
2022 | -28.73% | -65.81% |
The current ROE of Pell Bio-Med Technology Co., Ltd. (6949.TW) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
-31.94%
5-year avg
-44.96%
10-year avg
-44.96%
Pell Bio-Med Technology Co., Ltd.’s ROE is
Company | ROE | Market cap |
---|
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Pell Bio-Med Technology Co., Ltd. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Pell Bio-Med Technology Co., Ltd. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the ROE?
How can you use the ROE?
What is Pell Bio-Med Technology Co., Ltd.'s ROE?
How is the ROE calculated for Pell Bio-Med Technology Co., Ltd. (6949.TW)?
What is the highest ROE for Pell Bio-Med Technology Co., Ltd. (6949.TW)?
What is the 3-year average ROE for Pell Bio-Med Technology Co., Ltd. (6949.TW)?
What is the 5-year average ROE for Pell Bio-Med Technology Co., Ltd. (6949.TW)?
How does the current ROE for Pell Bio-Med Technology Co., Ltd. (6949.TW) compare to its historical average?